Clinical Trials Logo

Clinical Trial Summary

To investigate weight loss effect with mild calorie restriction on circulating levels of liver enzymes in nondiabetic and overweight subjects with high visceral fat area [visceral fat area (VFA) at L4 ≥ 100 cm²].


Clinical Trial Description

A 12-week randomized, placebo-controlled study was conducted on 80 nondiabetic and overweight subjects with high VFA. The participants divided into two groups: 12-week mild calorie restriction (a 300 kcal/day intake reduction, n=40) or no treatment (control, n=40). The randomization was according to computer-generated block randomization (placebo:test = 1:1). Before and after intervention period, venous blood samples were obtained from the subjects, and biochemical parameters including circulating liver enzymes were measured. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02992639
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date October 2016

See also
  Status Clinical Trial Phase
Completed NCT02754219 - Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction Phase 1
Terminated NCT01079104 - Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units N/A
Recruiting NCT00553553 - Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery N/A
Completed NCT03641872 - A Validation Cohort for ACLF Diagnosis and Prognosis
Completed NCT03371537 - Study of Hemodynamic Conditions Measured During Hepatectomy
Not yet recruiting NCT05559242 - Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients Phase 1
Recruiting NCT02473601 - Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis Phase 2
Completed NCT01000337 - Markers of Liver Apoptosis After Anesthesia With Sevoflurane or Propofol N/A
Completed NCT03155984 - Optimizing HBV Management During Anti-CD20 Antibodies
Recruiting NCT06126419 - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration N/A
Completed NCT03515980 - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function Phase 1
Completed NCT01338714 - The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function Phase 3
Completed NCT02005744 - A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function Phase 1
Completed NCT01367522 - Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function Phase 1
Recruiting NCT03805139 - Role of Ajwa Derived Polyphenols in Dyslipidaemias N/A
Enrolling by invitation NCT05082077 - Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Completed NCT02949505 - Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation N/A
Completed NCT02991339 - The Effects of Dexamethasone Administration on Jaundice Following Liver Resection Phase 2/Phase 3
Recruiting NCT05793203 - Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
Recruiting NCT03519074 - Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction Phase 2